These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17983452)

  • 1. Necrolytic migratory erythema in an opiate-dependent patient.
    Muller FM; Arseculeratne G; Evans A; Fleming C
    Clin Exp Dermatol; 2008 Jan; 33(1):40-2. PubMed ID: 17983452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrolytic acral erythema: a variant of necrolytic migratory erythema or a distinct entity?
    Nofal AA; Nofal E; Attwa E; El-Assar O; Assaf M
    Int J Dermatol; 2005 Nov; 44(11):916-21. PubMed ID: 16336523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
    Du Jardin P; Cools P; Van der Stighelen Y
    Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrolytic migratory erythema without glucagonoma in a patient with short bowel syndrome.
    Nakashima H; Komine M; Sasaki K; Mitsui H; Fujimoto M; Ihn H; Asahina A; Kikuchi K; Tamaki K
    J Dermatol; 2006 Aug; 33(8):557-62. PubMed ID: 16923138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural studies of necrolytic migratory erythema.
    Ohyama K; Kitoh M; Arao T
    Arch Dermatol; 1982 Sep; 118(9):679-82. PubMed ID: 6287944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone- and heroin-related deaths in Florida.
    Graham NA; Merlo LJ; Goldberger BA; Gold MS
    Am J Drug Alcohol Abuse; 2008; 34(3):347-53. PubMed ID: 18428077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating opioid dependency and coexistent chronic nonmalignant pain.
    Blondell RD; Ashrafioun L
    Am Fam Physician; 2008 Nov; 78(10):1132-3. PubMed ID: 19035061
    [No Abstract]   [Full Text] [Related]  

  • 9. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobehavioral effects of treatment for opiate withdrawal.
    Coyle MG; Ferguson A; Lagasse L; Liu J; Lester B
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F73-4. PubMed ID: 15613582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrolytic migratory erythema without glucagonoma associated with hepatitis B.
    Kitamura Y; Sato M; Hatamochi A; Yamazaki S
    Eur J Dermatol; 2005; 15(1):49-51. PubMed ID: 15701595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intertriginous eruption.
    Wolf R; Oumeish OY; Parish LC
    Clin Dermatol; 2011; 29(2):173-9. PubMed ID: 21396557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial Infarction associated with methadone and/or dihydrocodeine.
    Backmund M; Meyer K; Zwehl W; Nagengast O; Eichenlaub D
    Eur Addict Res; 2001 Mar; 7(1):37-9. PubMed ID: 11316924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrolytic migratory erythema without glucagonoma in patients with liver disease.
    Marinkovich MP; Botella R; Datloff J; Sangueza OP
    J Am Acad Dermatol; 1995 Apr; 32(4):604-9. PubMed ID: 7896950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.